BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Biodexa Pharmaceuticals Plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$0.39−0.07 (-14.36%)
Close on Oct 19, 2026
Share price
−$38.4594 (−98.99%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -0.00 GBP
- Free cash flow
- -£5.59M
Valuation needs the share price. It fills in once daily prices are connected and converted from GBP.
Twelve years at a glance
Fiscal years 2014 to 2025, GBP
Revenue
–
Gross profit
–
Operating income
-£8.65M
EPS, diluted
-0.00 GBP
Free cash flow
-£5.59M
Reported period